Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Januvia
Januvia
Intarcia’s diabetes treatment beats $6B Merck drug in head-to-head trial
Bizjournals.com
Tue, 08/18/15 - 09:26 pm
Intarcia
Merck
diabetes
type 2 diabetes
devices
ITCA 650
Januvia
AdverseEvents: Diabetes drug analysis flags heart failure, pancreatitis reports
Fierce Pharma
Tue, 06/16/15 - 12:08 pm
diabetes
side effects
heart failure
pancreatitis
Nesina
Takeda
Onglyza
AstraZeneca
Farixga
Byetta
Victoza
Januvia
Merck
Novo Nordisk
Giant Study Boosts Januvia, Merck's $6 Billion Drug
Forbes
Mon, 06/8/15 - 10:16 pm
Merck
Januvia
diabetes
Merck scores victory in India patent battle over top diabetes meds
Fierce Pharma
Fri, 05/15/15 - 11:03 am
Merck
India
patents
diabetes
Glenmark
Januvia
Janumet
Lucky 7 diabetes meds to join blockbuster club by 2020
Fierce Pharma Marketing
Tue, 05/12/15 - 04:27 pm
diabetes
Sanofi
Lantus
Merck
Januvia
Eli Lilly
Humalog
Novo Nordisk
Xultophy
Tresiba
Merck Gains Edge on Rivals With Results About its Diabetes Drug
WSJ Pharmalot
Wed, 04/29/15 - 09:20 am
Merck
diabetes
Januvia
AstraZeneca
Onglyza
Nesina
Cardiovascular Outcomes With Merck's Januvia: No Better Or Worse Than Conventional Care
Forbes
Tue, 04/28/15 - 09:41 am
Merck
Januvia
diabetes
Safety scare with AstraZeneca's diabetes drug could shake up the DPP-4 field
Fierce Biotech
Fri, 04/10/15 - 03:54 pm
AstraZeneca
Onglyza
diabetes
DPP-4 inhibitor
Takeda
Merck
Nesina
Januvia
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Humira
Sovaldi
Remicade
Enbrel
Lantus
Rituxan
Advair
Avastin
Herceptin
Januvia
Merck
AbbVie
Gilead Sciences
JNJ
Amgen
Pfizer
Sanofi
Roche
GSK
Merck Spars With British Columbia After its Diabetes Pill is Dropped
WSJ Pharmalot
Mon, 02/9/15 - 09:02 pm
Merck
Januvia
Canada
British Columbia
diabetes
Merck's weekly diabetes drug stacks up to blockbuster Januvia in Phase III
Fierce Biotech
Thu, 09/18/14 - 09:24 am
Merck
diabetes
Januvia
omarigliptin
MK-3102
Januvia Linked To Increase in Heart Failure Hospitalizations
Forbes
Thu, 07/3/14 - 09:35 am
Januvia
heart failure
diabetes
Merck
FDA eases worries regarding certain diabetes medications
Yahoo/Fly on the Wall
Thu, 02/27/14 - 08:19 am
FDA
diabetes
Merck
Januvia
Janumet
Novo Nordisk
Victoza
Bristol-Myers Squibb
Byetta
Bydureon
Merck's New Drugs Are Bringing New Hope
Seeking Alpha
Thu, 02/6/14 - 11:59 am
Merck
Januvia
China
India
MK-3475
Markets That Can Propel Merck
Forbes
Thu, 12/19/13 - 05:12 pm
Merck
Gardasil
lambrolizumab
Janumet
Januvia
3 Takeaways You Need to Know From Merck's Earnings
Motley Fool
Mon, 10/28/13 - 03:29 pm
Merck
earnings
Januvia
Singulair
Gardasil
The Numbers Behind The Job Cuts -- 5 Reasons Why Merck & Co. Was Forced To Wield The Axe
Forbes
Thu, 10/3/13 - 10:29 am
Merck
layoffs
Pfizer
Januvia
R&D
Avanir Pharma to co-promote Merck's diabetes drugs; shares rise
Reuters
Tue, 08/13/13 - 10:42 am
Avanir
Merck
diabetes
Januvia
Janumet
Janumet XR
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Seeking Alpha
Tue, 08/6/13 - 10:00 am
GLP-1 agonist
diabetes
Oramed
Biodel
Bristol-Myers Squibb
Eli Lilly
MannKind
Novo Nordisk
Merck
Afrezza
Januvia
Victoza
Are These Diabetes Drugs Safe After All?
Motley Fool
Thu, 08/1/13 - 09:17 am
Januvia
Merck
Byetta
Bristol-Myers Squibb
diabetes
type 2 diabetes
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »